These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21509384)

  • 21. An efficient one-pot synthesis of benzothiazolo-4β-anilino-podophyllotoxin congeners: DNA topoisomerase-II inhibition and anticancer activity.
    Kamal A; Kumar BA; Suresh P; Shankaraiah N; Kumar MS
    Bioorg Med Chem Lett; 2011 Jan; 21(1):350-3. PubMed ID: 21144748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Inhibition by ellipticine derivatives of the reactions catalysed by the topoisomerases: preferential inhibition of topoisomerase II].
    Douc-Rasy S; Multon E; Kayser A; Riou G
    C R Seances Acad Sci III; 1983; 296(19):899-904. PubMed ID: 6311366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An Efficient, one-pot synthesis of isomeric ellipticine derivatives through intramolecular imino-Diels-Alder reaction.
    Gaddam V; Nagarajan R
    Org Lett; 2008 May; 10(10):1975-8. PubMed ID: 18412351
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conformational properties of topoisomerase II inhibitors and sequence specificity of DNA cleavage.
    Palumbo M; Mabilia M; Pozzan A; Capranico G; Tinelli S; Zunino F
    J Mol Recognit; 1994 Sep; 7(3):227-31. PubMed ID: 7880548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. N-methylcarbamate derivatives of ellipticine and olivacine with cytotoxic activity against four human lung cancer cell lines.
    Ruckdeschel JC; Modi SP; el-Hamouly W; Portuese E; Archer S
    J Med Chem; 1992 Dec; 35(26):4854-7. PubMed ID: 1479585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design and synthesis of ellipticinium salts and 1,2-dihydroellipticines with high selectivities against human CNS cancers in vitro.
    Jurayj J; Haugwitz RD; Varma RK; Paull KD; Barrett JF; Cushman M
    J Med Chem; 1994 Jul; 37(14):2190-7. PubMed ID: 8035426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ellipticines as DNA-targeted chemotherapeutics.
    Stiborová M; Frei E
    Curr Med Chem; 2014; 21(5):575-91. PubMed ID: 24059226
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and biological evaluation of bengacarboline derivatives.
    Pouilhès A; Kouklovsky C; Langlois Y; Baltaze JP; Vispé S; Annereau JP; Barret JM; Kruczynski A; Bailly C
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1212-6. PubMed ID: 18083028
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and biological evaluation of N-substituted benzo[c]phenanthrolines and benzo[c]phenanthrolinones as antiproliferative agents.
    Genès C; Lenglet G; Depauw S; Nhili R; Prado S; David-Cordonnier MH; Michel S; Tillequin F; Porée FH
    Eur J Med Chem; 2011 Jun; 46(6):2117-31. PubMed ID: 21435753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Azatoxin is a mechanistic hybrid of the topoisomerase II-targeted anticancer drugs etoposide and ellipticine.
    Cline SD; Macdonald TL; Osheroff N
    Biochemistry; 1997 Oct; 36(42):13095-101. PubMed ID: 9335572
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and topoisomerase II inhibitory and cytotoxic activity of oxiranylmethoxy- and thiiranylmethoxy-chalcone derivatives.
    Na Y; Nam JM
    Bioorg Med Chem Lett; 2011 Jan; 21(1):211-4. PubMed ID: 21115246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [9-Nitro- and 9-amino-ellipticines and derivatives: synthesis and pharmacologic properties].
    Gansser C; Viel C; Malvy C; Cros S
    Farmaco Sci; 1980 Nov; 35(11):887-95. PubMed ID: 7450021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary challenges in the design of topoisomerase II inhibitors for cancer chemotherapy.
    Bailly C
    Chem Rev; 2012 Jul; 112(7):3611-40. PubMed ID: 22397403
    [No Abstract]   [Full Text] [Related]  

  • 34. Synthesis of 4β-N-polyaromatic substituted podophyllotoxins: DNA topoisomerase inhibition, anticancer and apoptosis-inducing activities.
    Kamal A; Kumar BA; Suresh P; Agrawal SK; Chashoo G; Singh SK; Saxena AK
    Bioorg Med Chem; 2010 Dec; 18(24):8493-500. PubMed ID: 21074444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Attempts to target antitumor drugs toward opioid receptor-rich mouse tumor cells with enkephalin-ellipticinium conjugates.
    Rigaudy P; Charcosset JY; Garbay-Jaureguiberry C; Jacquemin-Sablon A; Roques BP
    Cancer Res; 1989 Apr; 49(7):1836-42. PubMed ID: 2538235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A novel epoxypropoxy flavonoid derivative and topoisomerase II inhibitor, MHY336, induces apoptosis in prostate cancer cells.
    Patra N; De U; Kang JA; Kim JM; Ahn MY; Lee J; Jung JH; Chung HY; Moon HR; Kim HS
    Eur J Pharmacol; 2011 May; 658(2-3):98-107. PubMed ID: 21376033
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthetic Optimization of Ellipticine and Antitumor Activity of Novel Hexacyclic Derivatives of Ellipticine.
    Lin J; Tang M; Zhao R; Du Q; Shen L; Du G; Zhang Y; Li Y; Pan X
    Curr Pharm Des; 2019; 25(33):3578-3589. PubMed ID: 30947658
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioactivities and Action Mechanisms of Ellipticine Derivatives Reported Prior to 2023.
    Hou W; Xu XL; Huang LJ; Zhang ZY; Zhou ZN; Wang JY; Ouyang X; Xin SY; Zhang ZY; Xiong Y; Huang H; Lan JX
    Chem Biodivers; 2024 May; 21(5):e202400210. PubMed ID: 38433548
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and pharmacological evaluation of new methyloxiranylmethoxyxanthone analogues.
    Woo S; Kang DH; Nam JM; Lee CS; Ha EM; Lee ES; Kwon Y; Na Y
    Eur J Med Chem; 2010 Sep; 45(9):4221-8. PubMed ID: 20619511
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, biological evaluation, and molecular docking study of 3-(3'-heteroatom substituted-2'-hydroxy-1'-propyloxy) xanthone analogues as novel topoisomerase IIα catalytic inhibitor.
    Jun KY; Lee EY; Jung MJ; Lee OH; Lee ES; Park Choo HY; Na Y; Kwon Y
    Eur J Med Chem; 2011 Jun; 46(6):1964-71. PubMed ID: 21419530
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.